Can I Have a Lung Transplant for Lung Cancer?

Can a lung transplant be used as a treatment for lung cancer? If so, when. And why wouldn't a lung transplant work for most people with lung cancer?
Source: About.com Lung Cancer - Category: Cancer & Oncology Authors: Tags: health Source Type: news

Related Links:

CONCLUSIONS: To date, data on OS, quality of life, PFS, response rate, or short- and long-term AEs are available from small uncontrolled trials only. The three trials included heavily pretreated participants, which had previously undergone regimens of BV or ASCT. For these participants, median OS was not reached after follow-up times of at least 16 months (more than 50% of participants with a limited life expectancy were alive at this timepoint). Only one cohort out of three only reported quality of life, with limited follow-up data so that meaningful conclusions were not possible. Serious adverse events occurred rarely. C...
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research
ConclusionsLTX and liver resections due to CD/CS are rare and associated with an acceptable post-operative morbidity and low mortality. Surgical treatment should be performed as early as possible to avoid recurrent episodes of cholangitis or carcinogenesis.
Source: Journal of Visceral Surgery - Category: Surgery Source Type: research
Publication date: 2018Source: Respiratory Medicine Case Reports, Volume 25Author(s): Pradnya D. Patil, Samir Sultan, M. Frances Hahn, Sreeja Biswas Roy, Mitchell D. Ross, Hesham Abdelrazek, Ross M. Bremner, Nitika Thawani, Rajat Walia, Tanmay S. PanchabhaiAbstractPatients under consideration for lung transplantation as treatment for end-stage lung diseases such as idiopathic pulmonary fibrosis (IPF) often have risk factors such as a history of smoking or concomitant emphysema, both of which can predispose the patient to lung cancer. In fact, IPF itself increases the risk of lung cancer development by 6.8% to 20%. Solid org...
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
Publication date: July 2018Source: Journal of Integrative Medicine, Volume 16, Issue 4Author(s): Bin Luo, Zu-jun Que, Zhi-yi Zhou, Qing Wang, Chang-sheng Dong, Yi Jiang, Bing Hu, Hui Shi, Yu Jin, Jian-wen Liu, He-gen Li, Lin Wang, Jian-hui TianAbstractObjectiveEscape from the body’s immune response is a basic characteristic of lung cancer, and indoleamine-2,3-dioxygenase (IDO) plays a key role in mediating immune escape of non-small-cell lung cancer, which leads to recurrence and metastasis. Feiji Recipe, a compound Chinese herbal medicine, has the effect of stabilizing lesions and prolonging survival in patients wit...
Source: Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
ConclusionsLTX and liver resections due to CD/CS are rare and associated with an acceptable post-operative morbidity and low mortality. Surgical treatment should be performed as early as possible to avoid recurrent episodes of cholangitis or carcinogenesis.
Source: Journal of Visceral Surgery - Category: Surgery Source Type: research
Publication date: 2018Source: Respiratory Medicine Case Reports, Volume 25Author(s): Pradnya D. Patil, Samir Sultan, M. Frances Hahn, Sreeja Biswas Roy, Mitchell D. Ross, Hesham Abdelrazek, Ross M. Bremner, Nitika Thawani, Rajat Walia, Tanmay S. PanchabhaiAbstractPatients under consideration for lung transplantation as treatment for end-stage lung diseases such as idiopathic pulmonary fibrosis (IPF) often have risk factors such as a history of smoking or concomitant emphysema, both of which can predispose the patient to lung cancer. In fact, IPF itself increases the risk of lung cancer development by 6.8% to 20%. Solid org...
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
Publication date: July 2018Source: Journal of Integrative Medicine, Volume 16, Issue 4Author(s): Bin Luo, Zu-jun Que, Zhi-yi Zhou, Qing Wang, Chang-sheng Dong, Yi Jiang, Bing Hu, Hui Shi, Yu Jin, Jian-wen Liu, He-gen Li, Lin Wang, Jian-hui TianAbstractObjectiveEscape from the body’s immune response is a basic characteristic of lung cancer, and indoleamine-2,3-dioxygenase (IDO) plays a key role in mediating immune escape of non-small-cell lung cancer, which leads to recurrence and metastasis. Feiji Recipe, a compound Chinese herbal medicine, has the effect of stabilizing lesions and prolonging survival in patients wit...
Source: Journal of Integrative Medicine - Category: Complementary Medicine Source Type: research
Publication date: 2018 Source:Respiratory Medicine Case Reports, Volume 25 Author(s): Pradnya D. Patil, Samir Sultan, M. Frances Hahn, Sreeja Biswas Roy, Mitchell D. Ross, Hesham Abdelrazek, Ross M. Bremner, Nitika Thawani, Rajat Walia, Tanmay S. Panchabhai Patients under consideration for lung transplantation as treatment for end-stage lung diseases such as idiopathic pulmonary fibrosis (IPF) often have risk factors such as a history of smoking or concomitant emphysema, both of which can predispose the patient to lung cancer. In fact, IPF itself increases the risk of lung cancer development by 6.8% to 20%. Solid organ ma...
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
Rationale: Intrapleural hyperthermic chemotherapy (IPHC) is the preferred method to locally treat lung cancer with pleural seeding. Anesthetic management during IPHC is a very challenging task for the anesthesiologist because of the hemodynamic instability associated with the procedure; however, there is no report on anesthetic considerations during the IPHC procedure. Patient concerns: Three patients who diagnosed lung cancer with pleural invasion scheduled for IPHC were reported in this case series. Diagnosis: Case 1, a 48-year-old woman, suffered from lung cancer (adenocarcinoma, T2NxM1a) with diffuse pleural se...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
This case series describes 90-day mortality of patients who required tracheal, bronchial, or carinal reconstruction using stented aortic allografts supported by muscle flaps for treatment of inoperable airway disease including lung cancer, tracheal stenosis, or tracheomalacia.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Health | Lung Cancer | Lung Transplant | Transplant Surgery | Transplants